As part of the University of Bristol, Langford is the only referral hospital in the South West which has an educational facility.
The new academy will also offer access to its Recent Graduate Scheme for vets that have been qualified for less than five years, advanced CPD delivered by specialists, the chance to be involved in research collaborations with Bristol Vet School, and rotating internships and residencies.
Chloe Higgins MRCVS, who is on the Recent Graduate Scheme, said: "I recently did my first splenectomy and having done the abdominal emergencies session last month, it made both the surgery and all the discussion points with the owner a lot easier and less stressful!”
For more information, email: brm@langfordvets.co.uk
The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.
The new Vetoryl tablets will come in packs of 30 tablets, although no word from Dechra as to when they'll arrive.
Thomas Johnson, Vetoryl brand manager at Dechra, said: “We are delighted that Vetoryl Flavoured Tablets for Dogs will soon be available, which will provide vets and pets owners with easy to administer, flavoured tablets to provide additional dosing flexibility.
"This, together with our commitment to providing extensive technical support and resources, will ensure that Vetoryl continues to be the UK’s leading licensed medical treatment for Cushing’s syndrome.”
A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
Veterinary surgeons Lewis Grant and Professor Quintin McKellar have joined Dr Lydia Brown in the New Year's Honours List.
Mr Grant, former veterinary manager in the Meat Hygiene Service, Food Standards Agency and animal welfare representative of the Veterinary Public Health Association (VPHA) was awarded an MBE. Professor Quintin McKellar, Principal of the Royal Veterinary College has been awarded a CBE for services to science.
BVA Honorary Member the Earl of Selborne was also recognised with a GBE for services to science.
Harvey Locke, President of the BVA, said: "On behalf of the BVA I would like to congratulate Dr Brown, Lewis Grant, Professor McKellar and Lord Selborne on their fantastic achievements. These national honours underline the importance of veterinary medicine."
Spanish company Vital Dinamic has announced the launch of SD VET, a new stool designed to reduce the physical stress from prolonged standing whilst operating.
The stool is based on a multi-directional rocking design which gives the surgeon a wide range of movement whilst taking the weight off their legs (see video below).
In addition, the company says that SD VET protects the back from postural problems, helps circulation in the legs and puts the surgeon in a more relaxed posture, thereby helping to improve concentration on the task at hand.
For more information, contact: José de Benito, International Sales Director on +34 661 763 887 or email: jdebenito@vitaldinamic.com
Enrolment is now open for the programme, which matches participants with an experienced supervisor and provides BSAVA support and guidance.
The Association says the qualification is intended to give veterinary surgeons the opportunity to investigate in more depth any aspect of clinical research relating to their work – in particular vets working in practice, including those who may be unsure how to take the first step.
It could be a special interest, such as evaluating risk factors for a particular disease or common case they see in practice, with experienced peers available in diverse areas – from exotics to ophthalmology and nutrition to internal medicine.
The Masters is a significant addition to the most successful CPD programme in the 60-year history of the BSAVA, spearheaded by Academic Director Frances Barr (pictured above right).
Frances said: "This qualification offers exciting possibilities for vets to unlock their inner researcher, finding answers to clinical questions faced in practice and guided every step of the way by highly experienced supervisors and the BSAVA team.
"It furthers the BSAVA’s mission to help vets realise their ambitions and develop through lifelong learning at every stage of their careers, which we hope will have a very positive impact on the profession."
The Masters programme, validated by Nottingham Trent University, is aimed at people who already have any accredited postgraduate certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery.
It is based on a further 1,200 study hours and could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability. It starts with online study into the principles of clinical research, which students will then apply to their own research project.
The programme starts in January 2017 and applications are now open.
Students can enroll online and find out more information at www.bsava.com or by emailing masters@bsava.com.
The founders of ioLight, Andrew Monk and Richard Williams, will be in attendance on the Bayer stand to answer questions about the new product.
James Crawford, Head of Marketing at Bayer, said: "Bayer is delighted to present the ioLight microscope on our stand at the London Vet Show 2016. The microscope provides fantastically clear images and is simple to use, showing off Bayer's products for all our customers to see."
Professor Mike Taylor, a Diplomate of the European Veterinary Parasitology College, is in the process of evaluating the ioLight microscope as a tool for the diagnosis of parasitic infections of farm animals.
Normally he uses a laboratory microscope for this work but they are not routinely used on a farm. He has also tried a portable digital microscope, but finds it does not give the resolution required for identification of protozoan parasite species or for counting nematode eggs. Mike said: "The ioLight’s portability, image quality and connectivity to the Apple iPad offer great potential for the development of rapid methods for identifying parasites, or determining parasite burdens. I can envisage its use by both veterinarians and suitably trained livestock farmers, in the practice laboratory or directly on the farm."
Andrew Monk said: "Since our launch earlier this year we have seen a massive interest from the veterinary sector. We are thrilled to have the opportunity to demonstrate our microscope to such a large audience, and are looking forward to working with Bayer."
For more information visit iolight.co.uk or email Andrew Monk at andrew.monk@iolight.co.uk.
Launching this spring, CVS says it's the only programme of its type in the veterinary sector.
The programme will be open to all of CVS's young vets and will operate within all 12 of its farm practices in the England, Scotland and Northern Ireland.
Each CVS farm graduate vet will be able to go on an exchange in their second year of the programme and every placement will last up to two weeks.
The subject matter of each exchange will be at the direction of the graduate rather than following a specific programme, so participating graduates have the freedom to explore their own areas of interest.
Anna Bruguera Sala, Programme Co-ordinator and vet at Alnorthumbria Farm Vets, said: “The major benefits of our new graduate exchange programme is that it is open to all young vets of different levels of experience and provides bespoke learning opportunities tailored to each individual.
"It will also create connections, so experienced colleagues can support an exchange student with their new skillset when they are back within their own practice.”
www.careerswithcvs.co.uk
Apparently, there were over 100 times more recorded outbreaks of equine flu across the UK in 2019 than the year before1, and numerous equestrian events were cancelled as a result.
The company says that despite this, as of 2019, only about half of all UK horses are vaccinated2.
Blaise Scott-Morris MRCVS, Equine Marketing and Technical Manager at MSD Animal Health said: "Last year’s outbreaks of equine flu rocked the equine world, raising important animal welfare issues and costing the racing industry millions.
"Furthermore, they highlighted the need for good preventative healthcare and, in particular, vaccination. It’s vital that more owners are encouraged to vaccinate and those that already have, to keep up with their annual vaccinations and health checks so we don’t experience the same suffering again."
MSD's campaign invites horse owners to join the movement to #fightequineflu, and there is a range of materials to help practices promote the campaign and encourage clients to talk about vaccination and preventative healthcare, including an educational infographic poster, a social media pack and new resources on the Chameleon appointment reminder system.
MSD will itself be promoting the campaign on social media (Facebook: @Keeping Britains Horses Healthy, Instagram: @KeepingHorsesHealthy), and through partnerships with consumer channels such as Horse and Country TV.
There is also a new information resource online at www.kbhh.co.uk/achoo, which offers horse owners links to a range of other educational preventative health materials and horse care advice.
To request your Fight Equine Flu practice pack, speak to your MSD account manager.
References
The Animal Health Trust has cut the first sod of a new cancer centre for animals in Suffolk.
The AHT's Cancer Centre will provide all three treatment options: surgery, chemotherapy and radiotherapy, on one site. The cancer facility is being purpose-built to treat horses, dogs and cats.
Sue Murphy, Head of Clinical Cancer Treatment at the AHT, said: "Having all three treatment options on one site means that whatever the diagnosis, we will be able to offer each and every patient the very best options for their specific case. With one in four dogs and one in six cats developing cancer at some time in their life this new centre will help many more animals - from Suffolk, East Anglia and all across the UK."
The new centre will also further research into cancer. Treating animals with all types of the disease will enable the AHT's vets and scientists to expand current knowledge about cancer. This will help with the development of new ways to diagnose and treat the disease.
Vets and scientists at the AHT already work collaboratively with cancer researchers looking at the disease in humans. There are a number of links between human and animal cancers which have already been identified. It is hoped that knowledge gained from the AHT Cancer Centre may also help in the understanding of cancer in people.
The AHT hopes the building will open in summer 2012 . It is launching an appeal to raise much needed funds to equip the centre with a linear accelerator. This piece of specialist equipment works by delivering high-energy radiation beams to break cancerous tumours down while sparing the surrounding normal tissue.
The AHT Cancer Centre will be one of only six veterinary facilities in the UK to house a linear accelerator.
Sue Murphy added: "Currently, there is no way to tell which animals will, and which animals won't, develop cancer. It could happen to any animal at any time. This new centre will give more animals a fighting chance of beating the disease, enabling them to lead long and healthy lives. The fact that treatments developed to benefit our pets may also lead to improvements in the prevention and treatment of cancer in humans makes this centre all the more important.
"I would urge you to donate whatever you can to help equip the centre. Your donation, however large or small, will help many more animals beat cancer and it may also help in the fight against cancer in people."
If you would like to make a donation to the AHT Cancer Centre please visit www.aht.org.uk or telephone 01638 555648.
Alternatively you can make a £5 donation by textingVETS24 £5 to 70070
The RCVS Charitable Trust, has announced a complete rebranding that includes a change of name - RCVS Knowledge - and the refocus of its mission on supporting the flourishing evidence based veterinary medicine (EBVM) movement across the globe.
For the past 50 years, the charity has been known as a small funder of veterinary research and the home of the only freely-accessible library for the practising veterinary community in the UK.
Nick Royle, Executive Director of RCVS Knowledge said: "RCVS Knowledge is a name that encompasses our three core offerings: historical knowledge represented by our valuable Historical Collection, present knowledge, represented by our library, and future knowledge, represented by the new evidence based veterinary medicine project, which is underpinned by our grants programme."
The RCVS Knowledge re-launch goes further than a mere name change, and comes as the charity refocuses its efforts to become a global intermediary for EBVM, a direction reached following a period of consultation, and on the back of a successful symposium on the subject held at the end of 2012.
Nick, a former CEO of the human evidence based medicine resource, The Cochrane Collaboration, said: "Today, veterinary surgeons and nurses are required to take account of an ever-increasing pool of scientific data, the owners' values and preferences, and their own clinical expertise when making clinical decisions. RCVS Knowledge is ideally placed to generate, collate and distribute this information to support evidence based practices. We aim to develop tools to assist practitioners to quickly make well-informed treatment decisions."
As part of the new direction, the Historical Collection will be made accessible and available online, following a start-up grant from the Wellcome Trust. Clare Boulton, Head of Library and Information Services, said: "The Collection contains priceless and fascinating material, covering topics such as early horse-care and management, veterinary expeditions of discovery through Africa, and research that made the British Cavalry horses of 1914 the finest in the world. But this is just the beginning. If you have relevant experience or some funds that could help us, please get in touch."
Meanwhile, RCVS Knowledge's Library and Information Service will be re-designed to make it much more than shelves of journals, but rather a resource with the capacity to steer first-rate care and innovation, and an information engine capable of driving evidence based veterinary medicine at a global level.
The Grants and Awards program, for which the former RCVS Charitable Trust has been known, will be redesigned to celebrate professional excellence, and to address gaps in veterinary knowledge. Nick said: "We are aware of the responsibilities that veterinary surgeons and nurses face every day and feel we are in a position to support their decision making. We would like to urge every veterinary professional with an interest in EBVM, a curiosity about the history of their profession or a need to access up-to-date research to get in touch, so that we can keep you up to date with developments."
Over 500 practices took part in the 2016 initiative, and Avacta is hoping even more will get involved this year, helping to raise awareness of allergies in cats and dogs.
Marketing Manager Gary Skipper said: "This year’s PAW campaign will focus on the clinical signs associated with allergies in cats and dogs as well as what is involved in the diagnosis and treatment process."
To help raise the PAW profile, Avacta has created a series of cartoon characters, such as the one pictured right, to help engage pet owners with the initiative and demonstrate the clinical signs associated with allergies in pets. There'll be a competition to name the cartoon characters at Avacta's stand (808) at BSAVA Congress this year, for the chance to win a personal pet portrait.
Gary said: "There are a wealth of reasons to get the practice involved in the initiative. PAW aims to help boost awareness among clients of the common clinical signals associated with allergies in cats and dogs; we will be offering heavily discounted canine and feline allergy tests throughout June to help reduce costs, and the campaign also helps to encourage team work by getting everyone at the practice involved in the competition for the best PAW waiting room display using the pack materials – the winning practice will receive a luxury hamper!"
To register your practice for the 2017 Pet Allergy Week, complete the online registration form at www.avactaanimalhealth.com/PAW. Alternatively speak to your local Territory Manager or contact the Avacta Customer Services Team on 0800 3 047 047 or email customer.services@avacta.com.
The registration deadline to receive a pack is Friday 5th May.
Following two postponed hearings and a stayed Judicial Review, the Disciplinary Committee of the Royal College of Veterinary Surgeons last week accepted a wide-ranging 18-month programme of undertakings from a veterinary surgeon found guilty of serious professional misconduct, to address his "serious deficiencies" and "practice failings".
In October 2006, Mr Joseph Holmes MRCVS, of the Waltham Veterinary Clinic near Grimsby, was found guilty of serious professional misconduct for performing inappropriate and out-of-date veterinary treatment. Judgment was postponed for a period of two years subject to conditions that were put in writing and agreed by Mr Holmes.
The hearing resumed early, in February 2008, as Mr Holmes had deliberately ceased to comply with these conditions in the hope of forcing an appeal against the Committee's original finding of serious professional misconduct.
At the resumed hearing, Mr Holmes was told there was no legal framework for such an appeal (only against a sanction of suspension or removal from the Register) and that he would be subject to an 18-month period of compliance with the conditions set out at the original hearing; he was also invited to propose a programme of continuing professional development (CPD) and other undertakings for that period.
As Mr Holmes then applied for a Judicial Review of the Committee's decisions, this programme was never proposed. However, at the Royal Courts of Justice in October 2008, Mr Holmes' application for Judicial Review was stayed, by mutual consent, allowing for the DC hearing to be resumed and for him to offer undertakings for the Committee's consideration.
At last week's hearing, the Committee reminded itself of the original four findings of serious professional misconduct against Mr Holmes, which, in each case, it had stated would "be viewed by reasonable and competent members of the veterinary profession to be deplorable...and far below the standards that members of the public were entitled to expect."
In relation to these findings, the Committee was particularly concerned about his deficiencies in the fields of orthopaedics, oncology, radiology and therapeutics and considered that his future CPD should specifically address these areas.
Consequently, Mr Holmes agreed to an extensive range of undertakings over an 18-month period, including: participation in the RCVS Practice Standards Scheme (including two inspections); keeping abreast of changes to the RCVS Guide to Professional Conduct; 105 hours of standard and additional CPD; proofs of purchase of up-to-date text books and journal subscriptions; and six-monthly progress reports to the Chairman of the Committee.
Brian Jennings, Chairman of the Committee, said: "The Committee considers that the undertakings in the form that you have offered to it, if fulfilled by you, will serve to ensure that there will be no repetition of the conduct which resulted in our original findings and serve to ensure that animals and the public will not be put at risk.
"We trust that you will enter into these courses with the right mind-set and find that at their conclusion, these tasks have been of advantage to your practice."
Veterinary surgeons who can keep it short and sweet have a chance of receiving an all (reasonable) expenses paid trip to BVA Congress this September.
The RCVS Trust is offering to pay the registration fee, plus travel, food and accommodation costs for two nights for two vets to attend the whole conference.
The catch? Would-be delegates must have graduated within the past eight years and be able to explain - in fifty words or less - how this support would benefit them educationally.
Cherry Bushell, RCVS Trust Director said: "It is a bit of a light-hearted approach, however, the idea is to make relatively new vets think in a focused way about what they would get out of going to BVA Congress. They need to tell us how they will benefit educationally from the opportunity we're offering - it's not simply about financial need."
Applicants should send an email to info@rcvstrust.org.uk before 24 August, with their name and contact details and convince the Trust, in fifty words or less, that they would get the most out of attending BVA Congress. Only the first 100 emails received by the Trust will be considered. Registration fees will be paid directly to the BVA and all costs claimed must be reasonable.
The BVA 2009 Annual Congress will be held at the Mecure Holland House Hotel, Cardiff, from 24-26 September. For more details visit http://www.bva.co.uk/events/BVA_Congress.aspx.
The latest solution to the perennial problem of cat mess has arrived in the UK; CatGenie is the world's first self-flushing, self-washing cat loo.
They say a picture is worth a thousand words, so here it is...
According to CatGenie UK, the loo eliminates the need for pet owners to touch, smell or change dirty cat litter again, or carry heavy bags of cat litter home from the supermarket.
Once hooked up to a water connection and plugged into an electrical socket, CatGenie is ready to use. Instead of litter, it uses washable granules that look and feel like litter. Liquid waste drains and solids get scooped. All get liquefied for disposal down the drain, out of the home. The washable granules and cat box interior are then washed with water and SaniSolution. A built in dryer blows hot air through the granules to dry them completely for the cat's comfort. Sensors monitor when a cat visits the box and the CatGenie can be set to clean automatically at intervals throughout the day, or manually whenever required.
CatGenie costs £289.99 including VAT and shipping. The company says that annual running costs are lower than traditional cat litter methods which cost approximately £155/year, with more than 30 hours a year spent on buying and carrying litter, changing and disposing of dirty litter. CatGenie's on-going costs are less than £100.
CatGenie is offering vets the opportunity to take advantage of this product launch in the UK. By displaying CatGenie leaflets in your practice, you can earn £10 for every unit sold. There's no financial outlay and no need to store bulky items. Your leaflets will include a promotional code, unique to your practice. If one of your clients buys a CatGenie online and types in the code from one of your leaflets, you automatically receive £10 and they receive a £10 discount off the purchase price.
For further information on how to sign up to the promotional offer and for leaflets to display in your practice, please email courtney.morgan@catgenie.co.uk
Bioscience students from the Royal Veterinary College are more likely to be in industry relevant employment six months after graduation than any other institution in the UK, according to new university rankings.
The Guardian University Guide 2013 places the RVC's Bioveterinary Science programme eighth overall, out of 97 institutions across the UK. This represents a significant improvement on previous years - in the 2012 University Guide the RVC ranked 31st overall and in 2011 was placed 46th.
The RVC also ranks top for student satisfaction of both the course overall and the standard of teaching - 100% and 99% respectively. This success follows a focus on improving student experience across the College with the RVC picking up the 2012 Times Higher Education award for Most Improved Student Experience.
Professor Stephen May, vice-principal for teaching at the Royal Veterinary College, said: "It is a fantastic achievement to see our Bioveterinary Sciences programme performing so well, especially in terms of student satisfaction and employment. The success of this programme indicates the College's firm belief that veterinary science is much bigger than just veterinary practice; the combination of veterinary medicine, human medicine and environmental science will, in future, be essential to tackling some of the biggest health issues in society."
Virbac has announced that Canine Prostate Awareness Month, its initiative to highlight the prevalence of Benign Prostatic Hyperplasia (BPH), will be running again in November, and is urging practices to join in.
The initiative is timed to coincide with Movember, the fundraising initiative for male prostate disease and testicular cancer. Virbac says it hopes CPAM will remind owners that men are not the only ones to suffer from prostate disorders. Indeed, more than 80% of entire male dogs over the age of five are thought to suffer from BPH1.
As part of CPAM, Virbac is providing participating practices with promotional materials including owner educational and display materials, a template press release for local media, and free branded slip leads to pass on to owners who have had their dog checked.
Chris Geddes MRCVS, Senior Product Manager, said: "CPAM is a well-supported initiative and, running it at a time when the media spotlight is already on the dangers of prostate cancer in men, means we can spread the message that owners should also be monitoring older dogs for signs of prostate disease."
Virbac has introduced Odelis CPSE, the first ELISA test to screen for, diagnose and monitor BPH. It is available from three UK diagnostic laboratories. According to the company it is a cost-effective, precise and reliable alternative to rectal palpation. It also offers Ypozane, a tablet treatment for BPH, which takes effect within a week and lasts for six months.
Chris added: "The problem with BPH is that the majority of dogs suffer in silence. It is a painful condition that goes unnoticed until it reaches an advanced stage, where the owner notices blood in the urine or painful urination.
"We're providing practices with all the materials they need to promote the campaign in their locality and hope that those getting involved will find it effective in terms of bringing clients into the practice for advice on BPH. We've also organised coverage in national dog magazines to drive clients to practices."
Practices that diagnose a dog with BPH during CPAM are asked to contact Virbac with details as it plans to collate a series of case studies from the initiative. Love2Shop vouchers to the value of £50 will be provided for the five most pertinent case studies submitted by the end of 2013.
For further information on CPAM, email cpam@virbac.co.uk, contact your Virbac Territory Manager or call the company direct on 01359 243243.
Reference
BVA’s Voice of the Veterinary Profession survey found that 9 in 10 vets do work for which they charge but are subsequently not paid, with the monthly average bad debt reported to be £676.
To help its members, BVA undertook a detailed tender process for a new debt recovery partner before selecting LRC.
LRC offers a range of customisable debt recovery services, including pre-legal collections, legal collections and enforcement services. The BVA says it is one of the few debt recovery agencies in the UK to have been granted a licence by the Solicitors Regulation Authority (SRA), allowing it to operate as a legal firm under the Alternative Business Structure (ABS). This enables it to conduct litigation (court action) in its own name, without having to partner with a third party law firm.
BVA President Sean Wensley said: "We are very pleased to be offering this service to members at a reduced rate following a thorough process to select our debt recovery partner, during which we received excellent testimonials about LRC, including from veterinary businesses. Veterinary practices need to be sustainable businesses if they are to continue caring for animals and bad debt impacts on vets’ work. Having a reliable partner to recover bad debt is a welcome addition to the services BVA offers our members."
To access LRC’s debt recovery services at preferential rates, BVA members should contact LRC directly by calling 0330 024 6350 or emailing michaelwhitaker@legalrecoveries.com They will need to quote their membership number.
More information can be found on the BVA website at www.bva.co.uk/lrc
According to the Veterinary Medicines Directorate, the company has identified that there is a small possibility that some syringes from the batches listed below have not been correctly sterilised. These batches are therefore being recalled from the market with immediate effect to the veterinary practice level.
This issue impacts on the following batches that have been placed on the UK market:
Zoetis is contacting wholesale dealers and veterinary surgeons to arrange return of affected batches.
If you have any queries in relation to the recall, or wish to report a suspected adverse reaction, contact Zoetis Technical Services on 0845 300 8034, option 1.
Dr Mark Johnston, CEO of Vetstream said: “The usage data of Vetlexicon has continually shown us how important the client factsheets are to practices helping clients understand the health and welfare of their animals.
"Whilst most of our subscribers are accepting of the Vetlexicon content in English, the preferred language of many pet owners is not necessarily English, and we wanted to help practices with that.
"So a major new dimension to the new Vetlexicon website is to enable the content to be made available in many European and Asian languages so that when you are viewing a client factsheet, you can instantly see that content in Spanish, French or Korean and then print it out on paper and give to the owners for them to share with friends or family on their return to home; or to print it as a PDF and email it to them.
"Practices have told us that this will be so useful for the relationship with their clients, and so it is great to be able to provide that now.”
The company says it has also improved the interface and functionality of the site and made it mobile phone friendly.
www.vetlexicon.com
VetSurgeon.org member Dr Sarah Caney's company, Cat Professional, is conducting a survey of owner experiences of caring for cats with chronic kidney disease and is looking for practices to help recruit participants.
Recruited practices will be given a complimentary print copy of the new client education book 'Caring for a cat with chronic kidney disease' by Dr Sarah Caney and a set of flyers to give out to eligible cat owners.
Owners completing the survey will each receive a complimentary electronic copy of the same book.
The book is aimed at owners and aims to support veterinary recommendations regarding management of this common condition.
To find out more about this survey please visit http://www.catprofessional.com/ or contact Dr Sarah Caney on 07711 390219.
Pfizer Animal Health, maker of the equine wormers Equest & Equest Pramox, has launched Stable Mate, a new app to help horse owners manage their daily equine healthcare regime and get maximum enjoyment from their horse.
Pfizer says the new app has been described by testers as 'undoubtedly the best equestrian electronic management system you could wish for'. It includes an organiser in which to keep horses' records and details of their management requirements. It also includes Track My Ride, a GPS mapping and exercise planning service, and a news feed direct from Horse & Hound.
Stable Mate allows users to keep records for up to six horses on their iPhone. They just need to enter the information needed to keep track of each horse's health routine, including worm control, vaccinations, dentistry, farriery and feeding regime. The app then creates a calendar of events, appointments and reminders designed to make it easy for owners to keep their horse's essential healthcare needs on course.
Records can be passed to a yard manager or friends when the owner goes on holiday, making a temporary transfer of care straightforward. Stable Mate also offers general equine health advice, from the essentials of pasture management to understanding vaccination protocols.
Track My Ride is a GPS navigation system that allows owners to map the route, duration and speed of each ride. Pfizer says it's a great device for planning and monitoring exercise programmes, that owners can use it to explore new hacking routes safely and that they'll never have to worry about finding their way back to their horse box again when hunting or doing a long distance ride. Details of each ride are stored in a history log and can be shared with friends through social media.
Paul Blanc, Pfizer's equine brand manager said: "We have tried to develop an app that is all about the horse and their owner, making it as easy as possible for owners to keep their equine health care on track as well as add to the fun and pleasure with their horse. Stable Mate has well and truly surpassed our expectations. We hope that owners and riders find Stable Mate useful and enjoyable."
Stable Mate is currently available only for iPhone with Android and Blackberry coming soon.
Stable Mate is available free from the iPhone App Store http://itunes.apple.com/us/app/stable-mate/id532341393?ls=1&mt=8. To find out more visit www.wormingyourhorse.info.
The British Small Animal Association has responded to Defra's statement on compulsory microchipping.
The Association says it is an advocate of compulsory microchipping as the most effective way to permanently identify a dog - as long as owners maintain an up-to-date registration on the various databases. As such it broadly welcomes the recent Defra statement.
However, BSAVA points out that the statement has come before a full and considered consultation in terms of its implementation, and says it raises a number of questions for vets in practice:
Despite the headlines around the statement, this is yet to be laid down in law and will require changes under the Animal Welfare Act and potentially the Dangerous Dogs Act, so there is still a conversation to be had about its implementation.
For this reason BSAVA has announced that it is launching a consultation with its members to establish their concerns and opinions in order to work with all the organisations involved in the best interest of animal welfare and the profession. If anyone in practice wants to feed into this consultation, they should visit http://www.bsava.com or contact BSAVA's Scientific Policy Officer Sally Everitt via email - s.everitt@bsava.com.
BSAVA President Mark Johnston said: "While implantation can be straightforward for those with appropriate experience it will be important to ensure that all those who carry out implantation are properly trained. However microchipping is not just a matter of implanting the microchip, there is a significant amount of administrative work in ensuring that animals are properly registered and that details are kept up-to-date. All of these stages need to be properly funded if the scheme is to be successful and sustainable. BSAVA will be consulting its members to gather their views and concerns and hope to be involved in a productive conversation with all interested parties."
BSAVA says there is a good news animal welfare story within this statement concerning the seizure of animals during investigation under the Dangerous Dogs Act. The new measures will allow the authorities to decide whether a suspected prohibited dog can stay with their owners until the outcome of court proceedings. Until now all such animals had to be kennelled until the proceedings had concluded, which often means that dogs who posed no risk suffered unnecessarily. BSAVA welcomes this new measure in the interest of animal welfare.
VetsSouth, the new CPD congress and commercial exhibition being held in Exeter on 11th and 12th February, has announced that it will lead with a discussion about what practices can do to reduce bovine TB in clients' herds in 2015.
The congress, which is open to practising vets throughout the UK but aimed specifically at those in the west and south of the UK, will have three-and-half hours of discussion led by Roger Blowey (pictured right) and Richard Gard, with contributions from a number of practices in Gloucestershire, Devon, Somerset and Cornwall.
During a day on "cattle" on the Wednesday, Roger Blowey will also lead two sessions on "Recent dramatic changes in our understanding of cattle lameness", covering anatomy and foot lesions in the first and moving on to digital dermatitis and other infectious lesions in the second.
The rest of the programme is concerned mainly with small animals, the line-up of speakers including Dr David Williams on ophthalmology, Matthew Oxford on dentistry, Dr Andy Sparkes on feline medicine and surgery, Sarah Health on canine and feline behaviour and Anthony Chadwick on dermatology; plus six speakers from the Bristol veterinary school: Dr Jo Murrell and Gwen Covey-Crump on pain management, Dr Domingo Casamian Sorrosal and Dr Sonia Fonfara on cardiology, and Guillaume Chanoit and Ivan Doran on soft tissue surgery.
In addition, Professor John and Mrs Margaret Cooper will lead a day-long seminar on veterinary forensic medicine; the VDS will be running half-hour one-on-one sessions on improving consultation techniques; and there will be workshops on "ocular examination and pathology", "cat-friendly clinics" and "practical tooth extraction".
Exhibitors include Langford Veterinary Services, Vets4Pets/Companion Care, Protexin, Summit Veterinary Pharmaceuticals, Dechra Veterinary Products, Royal Canin, Bayer Animal Health, Natures Menu, Pet Medic Recruitment/Mi Vet, Teignview Veterinary Group, Henry Schein Animal Health, Axiom Veterinary Laboratories, iM3 Dental, Medimark Scientific, Merial Animal Health, Nova Laboratories, Improve International, DVH Veterinary Sales, Centaur Services, A. Menarini Diagnostics, The Webinar Vet and Improve International.
The event is being run by VP CPD in association with Improve International and The Webinar Vet, with generous sponsorship from Dechra Veterinary Products. Attendance on both days is priced at £145 (plus VAT); one-day passes cost £80 (plus VAT) with additional charges for the workshops and VDS sessions. The prices include speaker notes, refreshments throughout each day and a buffet lunch. CPD certificates will be sent on request after the event.
Full details and a booking form are on www.vetssouth.com.